Fair Market Value Calculator Steering Committee

  • Kate Avery, Director of Research, Beyond Celiac
  • John Boyle (and Lynn Albizo), President & CEO, Immune Deficiency Foundation
  • Barbara Collura, President & Chief Executive Officer, RESOLVE
  • Louisa M. Daniels, Vice President & Assistant General Counsel, Chief Counsel, Global Product Development, Pfizer
  • Tracy Hart, Chief Executive Officer, Osteogenesis Imperfecta Foundation
  • Louise Vetter , President & Chief Executive Officer, Huntington’s Disease Society of America

Tools to Support Sponsor-Patient Engagement: Fair-Market-Value Calculator and Engagement Templates

Tools to Support Sponsor-Patient Engagement: Fair-Market-Value Calculator and Engagement Templates

The NHC wants to ensure that all stakeholders confidently enter into ongoing, compliant, and sustainable engagement efforts that effectively drive health care innovation based on patient and caregiver insights, which must be collected in a trusted and high-quality manner. This project aims to support sustainable agreements between stakeholders and the patient and caregiver community as part of medical product development by:

Glossary of Patient Engagement Terms

Glossary of Patient Engagement Terms

 

The definitions of these terms, which includes Family Caregiver, Meaningful Engagement, and Patient-Focused Drug Development, stem largely from our patient engagement work, including our ‘Patient-Focused Drug Development -  Recommended Language for Use in Guidance Document Development’ Paper with Genetic Alliance, as well as our Value Rubric, and Representativeness Rubric.

Webinars

Upcoming Webinars

Clinical Outcome Assessments: Build New or Adapt Old?

Oct. 10, 2019 - This webinar will feature Stacie Hudgens, MA, Chief Executive Officer, Strategic Lead, Regulatory & Access at Clinical Outcomes Solutions. Register here.

Pages

Subscribe to RSS - Resources